JW Life Science Corp banner

JW Life Science Corp
KRX:234080

Watchlist Manager
JW Life Science Corp Logo
JW Life Science Corp
KRX:234080
Watchlist
Price: 13 480 KRW 1.81% Market Closed
Market Cap: ₩213.4B

JW Life Science Corp
Investor Relations

JW Life Science Corp. manufactures intravenous fluids. The company is headquartered in Dangjin, Chungcheongnam-Do. The company went IPO on 2016-10-27. The firm is engaged in manufacture of basic IV fluid including water, electrolytes and glucose; nutrient infusion solution including amino acids, lipids, proteins, vitamins and minerals; and special infusion solution, which is used in special cases. The firm is also engaged in manufacture of total parenteral nutrition (TPN) products and others.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Sungnam Cha
CEO & Director
No Bio Available
Jeong Yeol Noh
Executive Director & Head of HP Research Center
No Bio Available
Na Sook Hee
Executive Director
No Bio Available

Contacts

Address
CHUNGCHEONGNAM-DO
DANGJIN
28, Hanjin 1-gil, Songak-eup
Contacts